drugset / Trial / NCT01773096

Methylnaltrexone Use for Opioid-induced Postoperative Constipation

NCT01773096

Phase 4 Completed 60 enrolled Shriners Hospitals for Children
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to determine whether the routine use of methylnaltrexone in the post-operative pediatric spinal fusion patient will decrease the incidence of constipation.

Timeline

Start
2013-05
Primary completion
2015-05
Completion
2015-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Methylnaltrexone Other / unclassified 0.15 mg/kg
Subject Methylnaltrexone Other / unclassified 8 mg
Subject Methylnaltrexone Other / unclassified 12 mg
Background Bisacodyl Small molecule
Background Docusate Sodium Unknown
Background Senna Traditional medicine (herbal / TCM)
Background magnesium hydroxide Unknown
Background polyethylene glycol Other / unclassified

Indications